Centessa Pharmaceuticals

14.57
0.06 (0.41%)
At close: Mar 28, 2025, 3:59 PM
13.62
-6.52%
Pre-market: Mar 31, 2025, 04:29 AM EDT

Centessa Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 383.22M 128.03M 393.64M 595.08M 7.23M
Short-Term Investments 98.96M 128.52M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 2.05M 2.55M 45.98M 34.39M 552K
Receivables n/a 39.15M 26.72M 16.81M n/a
Inventory n/a 1.00 -29.99M -17.81M 1M
Other Current Assets 54.23M 19.39M 17.38M 16.88M 3.94M
Total Current Assets 536.41M 315.09M 393.64M 595.08M 11.16M
Property-Plant & Equipment 11.76M 12.95M 1.17M 162K n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 40.39M 45.15M 50.66M 34.55M 552K
Total Assets 576.8M 360.25M 444.31M 629.63M 11.72M
Account Payables 7.14M 11.81M 13.84M 7.3M 1.03M
Deferred Revenue n/a n/a n/a n/a 1.04M
Short-Term Debt n/a n/a n/a n/a 5.63M
Other Current Liabilities 50.02M 27.46M 22.92M 16.57M 1.96M
Total Current Liabilities 58M 39.38M 38.34M 24.64M 8.62M
Long-Term Debt 8.29M 84.59M 69.8M 75.7M n/a
Other Long-Term Liabilities 108.97M 29K n/a 37.74M n/a
Total Long-Term Liabilities 117.25M 84.62M 108.14M 138.08M 25.52M
Total Liabilities 175.25M 124M 108.14M 138.08M 34.14M
Total Debt 8.29M 84.59M 69.8M 75.7M 5.63M
Common Stock 359K 273K 265K 252K 21K
Retained Earnings -988.7M -752.95M -601.86M -385.65M -22.42M
Comprehensive Income 4.21M 1.49M -1.5M 688K -86K
Shareholders Equity 401.55M 236.24M 336.17M 491.55M -22.42M
Total Investments 98.96M 128.52M n/a n/a n/a